1. Academic Validation
  2. Drug Therapy for Acute Heart Failure

Drug Therapy for Acute Heart Failure

  • Rev Esp Cardiol (Engl Ed). 2015 Aug;68(8):706-13. doi: 10.1016/j.rec.2015.02.019.
Salvatore Di Somma 1 Laura Magrini 2
Affiliations

Affiliations

  • 1 Emergency Department Sant'Andrea Hospital, Medical-Surgery Sciences and Translational Medicine, University La Sapienza, Rome, Italy. Electronic address: salvatore.disomma@uniroma1.it.
  • 2 Emergency Department Sant'Andrea Hospital, Medical-Surgery Sciences and Translational Medicine, University La Sapienza, Rome, Italy.
Abstract

Acute heart failure is globally one of most frequent reasons for hospitalization and still represents a challenge for the choice of the best treatment to improve patient outcome. According to current international guidelines, as soon as patients with acute heart failure arrive at the emergency department, the common therapeutic approach aims to improve their signs and symptoms, correct volume overload, and ameliorate cardiac hemodynamics by increasing vital organ perfusion. Recommended treatment for the early management of acute heart failure is characterized by the use of intravenous diuretics, oxygen, and vasodilators. Although these measures ameliorate the patient's symptoms, they do not favorably impact on short- and long-term mortality. Consequently, there is a pressing need for novel agents in acute heart failure treatment with the result that research in this field is increasing worldwide.

Keywords

Acute heart failure; Drug therapy; Emergency department; Hospitalización; Hospitalization; Insuficiencia cardiaca aguda; Servicio de urgencias; Tratamiento farmacológico.

Figures